Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-742X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products ; day:4 ; month:6 ; year:2020 ; pages:1-8
Journal of thrombosis and thrombolysis ; (4.6.2020), 1-8
- Creator
-
Castillo, Renee
Chan, Alissa
Atallah, Steven
Derry, Katrina
Baje, Mark
Zimmermann, Lara L.
Martin, Ryan
Groysman, Leonid
Stern-Nezer, Sara
Minokadeh, Anush
Nova, Alan
Huang, WanTing
Cang, William
Schomer, Kendra
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11239-020-02154-z
- URN
-
urn:nbn:de:101:1-2020121418245315243801
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Castillo, Renee
- Chan, Alissa
- Atallah, Steven
- Derry, Katrina
- Baje, Mark
- Zimmermann, Lara L.
- Martin, Ryan
- Groysman, Leonid
- Stern-Nezer, Sara
- Minokadeh, Anush
- Nova, Alan
- Huang, WanTing
- Cang, William
- Schomer, Kendra
- SpringerLink (Online service)
Other Objects (12)
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
Role of prothrombin complex concentrate in perioperative coagulation therapy
Innovative Antithrombotika : Ticagrelor, Prasugrel, Elinogrel, Rivaroxaban, Apixaban, Edoxaban, Dabigatran, Vorapaxar, Atopaxar
Antikoagulation bei Vorhofflimmern – Dabigatran, Rivaroxaban oder Apixaban – die Qual der Wahl?
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
Shorter hospital stays in epistaxis patients taking Rivaroxaban and Apixaban vs. Phenprocoumon
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
Role of prothrombin complex concentrate in perioperative coagulation therapy
Innovative Antithrombotika : Ticagrelor, Prasugrel, Elinogrel, Rivaroxaban, Apixaban, Edoxaban, Dabigatran, Vorapaxar, Atopaxar
Antikoagulation bei Vorhofflimmern – Dabigatran, Rivaroxaban oder Apixaban – die Qual der Wahl?
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
Shorter hospital stays in epistaxis patients taking Rivaroxaban and Apixaban vs. Phenprocoumon
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
Role of prothrombin complex concentrate in perioperative coagulation therapy
Innovative Antithrombotika : Ticagrelor, Prasugrel, Elinogrel, Rivaroxaban, Apixaban, Edoxaban, Dabigatran, Vorapaxar, Atopaxar
Antikoagulation bei Vorhofflimmern – Dabigatran, Rivaroxaban oder Apixaban – die Qual der Wahl?
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding